ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #4,609Hybrid

Immunology Letters

Acronym:imlet
•
Abbreviation (ISO):IMMUNOL. LETT
•
Identifier (ISSN):0165-2478(Print)/1879-0542(Online)
•
Publisher:Elsevier
Clarivate IF (2026)
3.2↑ +0.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Immunology Letters

WoS Q3
13462.4420182.5520193.2820203.6920214.2320224.420233.320242.820253.22026
Annual Impact Factor Metric
Current (2026):3.2
Scopus SJR & RankScopus Q2
1.038
#4,609

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
118

118 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
103articles/year
32.22% Gold OA•91.25% Original Research

Aims & Scope

Immunology Letters provides a vehicle for the speedy publication of experimental papers, (mini)Reviews and Letters to the Editor addressing all aspects of molecular and cellular immunology. The essential criteria for publication will be clarity, experimental soundness and novelty. Results contradictory to current accepted thinking or ideas divergent from actual dogmas will be considered for publication provided that they are based on solid experimental findings. Preference will be given to papers of immediate importance to other investigators, either by their experimental data, new ideas or new methodology. Scientific correspondence to the Editor-in-Chief related to the published papers may also be accepted provided that they are short and scientifically relevant to the papers mentioned, in order to provide a continuing forum for discussion.

Topics Covered (Recognized by AI)
BiologyMedicineGeneticsImmunologyChemistryBiochemistryInternal MedicineImmune SystemCell BiologyAntibodies & ImmunologyMolecular BiologyPathologyEndocrinologyReceptors & Pharmacology
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

IMMUNOLOGY

Q3
Rank103/183
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q3
Rank100/183
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.2
Articles / Year84
Total Citations32
2025
IF2.8
Articles / Year119
Total Citations359
2024
IF3.3
Articles / Year95
Total Citations536
2023
IF4.4
Articles / Year103
Total Citations917
2022
IF4.23
Articles / Year85
Total Citations1,122

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,609Scopus Q2SCImago Profile
Scopus Coverage:1979-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q2
1.038

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.03

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,301 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations814
3-Year Documents263
Citable Documents244

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate50.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ2
Immunology and AllergyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区IMMUNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Immunology Letters (acronym: imlet, abbr: IMMUNOL. LETT, ISSN: 0165-2478) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier in Netherlands. The periodical holds a Journal Impact Factor (JIF) of 3.20, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 1.038 (Q2), an H-index of 118.

The journal enforces rigorous peer evaluation with an average review speed of 8.1周, a publication frequency of Monthly, an annual output of approximately 103 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,301 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier
Publication Language
Multi-Language
Frequency
Monthly
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 064ba94a-3cc5-468f-a6cf-09e6ebadfdb7
Database Updated: 2026-10-16